Birgitta Leuthner

1.5k total citations
22 papers, 784 citations indexed

About

Birgitta Leuthner is a scholar working on Molecular Biology, Oncology and Pollution. According to data from OpenAlex, Birgitta Leuthner has authored 22 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Pollution. Recurrent topics in Birgitta Leuthner's work include Peptidase Inhibition and Analysis (6 papers), Microbial bioremediation and biosurfactants (4 papers) and Microbial Metabolic Engineering and Bioproduction (4 papers). Birgitta Leuthner is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Microbial bioremediation and biosurfactants (4 papers) and Microbial Metabolic Engineering and Bioproduction (4 papers). Birgitta Leuthner collaborates with scholars based in Germany, United States and India. Birgitta Leuthner's co-authors include Johann Heider, Hermann Schägger, Wolfgang Haehnel, Patric Hörth, Christina Leutwein, Henk Schulz, Emile Schiltz, Michael Bölker, Peter Schreier and Olaf Müller and has published in prestigious journals such as Journal of Molecular Biology, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Birgitta Leuthner

22 papers receiving 765 citations

Peers

Countries citing papers authored by Birgitta Leuthner

Since Specialization

Citations

This map shows the geographic impact of Birgitta Leuthner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitta Leuthner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitta Leuthner more than expected).

Fields of papers citing papers by Birgitta Leuthner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitta Leuthner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitta Leuthner. The network helps show where Birgitta Leuthner may publish in the future.

Co-authorship network of co-authors of Birgitta Leuthner

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitta Leuthner. A scholar is included among the top collaborators of Birgitta Leuthner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitta Leuthner. Birgitta Leuthner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer 2025 ·Molecular Cancer Therapeutics ·Christina Esdar, Nina Linde, Andreas Blum, (unknown), (unknown), (unknown), Carl Petersson, Edith Ross, Birgitta Leuthner, Ulrich Grädler, Dieter Dorsch, Andree Blaukat	1
2	Discovery of potent allosteric antibodies inhibiting EGFR 2024 ·mAbs ·(unknown), Lukas Pekar, Birgitta Leuthner, Harald Kolmar, Lars Toleikis, Stefan Becker	4
3	Cryo-EM Structures of CRAF2/14-3-32 and CRAF2/14-3-32/MEK12 Complexes 2024 ·Journal of Molecular Biology ·Dirk Dedden, (unknown), Elisabeth V. Schneider, Maren Thomsen, Dániel Schwarz, Birgitta Leuthner, Ulrich Grädler	4
4	Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models 2023 ·Molecular Cancer Therapeutics ·Manja Friese‐Hamim, (unknown), Olga Bogatyrova, (unknown), Felix Rohdich, Beatrix Blume, Birgitta Leuthner, Frank Czauderna, Diane Hahn, Julia Jabs, (unknown), Timo Heinrich, Roland Kellner, Katherine Chan, Amy H.Y. Tong, Dirk Wienke, Jason Moffat, Andree Blaukat, Frank T. Zenke	1
5	Systematic Potency and Property Assessment of VHL Ligands and Implications on PROTAC Design 2023 ·ChemMedChem ·(unknown), F.J. Sorrell, Ansgar Wegener, Birgitta Leuthner, (unknown), Martin Hecht, (unknown), (unknown), (unknown), Ingo V. Hartung, (unknown)	28
6	Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal Retention 2022 ·Molecular Pharmacology ·(unknown), (unknown), (unknown), (unknown), Dániel Schwarz, Joerg Bomke, Birgitta Leuthner, Dominique Perrin, Oliver Schadt	3
7	Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models 2021 ·Journal of Medicinal Chemistry ·Hans‐Peter Buchstaller, (unknown), Dieter Dorsch, (unknown), Daniel Kühn, Martin Lehmann, Birgitta Leuthner, (unknown), Djordje Müsil, (unknown), (unknown), (unknown), Felix Rohdich, Richard Schneider, Ansgar Wegener, Stefan Weigt, (unknown), Christina Esdar	6
8	Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·Ulrich Grädler, Michael Busch, Birgitta Leuthner, (unknown), Lars T. Burgdorf, Martin Lehmann, Nina Linde, Christina Esdar	9
9	Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies 2019 ·Bioorganic & Medicinal Chemistry Letters ·Ulrich Grädler, Dániel Schwarz, M. Blaesse, Birgitta Leuthner, Theresa Johnson, Frédéric Bernard, Xuliang Jiang, (unknown), (unknown), (unknown), (unknown), Catherine Jorand‐Lebrun	33
10	A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors 2019 ·Scientific Reports ·Malini Menon, Richard Elliott, (unknown), (unknown), Rumana Rafiq, Sara Costa-Cabral, Felix M. Munkonge, (unknown), Roderick A. Porter, Andrew D. Campbell, Emma Johnson, Christina Esdar, Hans‐Peter Buchstaller, Birgitta Leuthner, Felix Rohdich, Richard Schneider, Owen J. Sansom, Dirk Wienke, Alan Ashworth, Christopher J. Lord	39
11	Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer 2019 ·Journal of Medicinal Chemistry ·Timo Heinrich, Jeyaprakashnarayanan Seenisamy, Frank Becker, Beatrix Blume, Jörg Bomke, (unknown), (unknown), Manja Friese‐Hamim, Jakub Gunera, Kerrin Hansen, Birgitta Leuthner, Djordje Müsil, (unknown), Felix Rohdich, Christian Siegl, (unknown), Ansgar Wegener, Frank T. Zenke	24
12	Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity 2019 ·Journal of Medicinal Chemistry ·Hans‐Peter Buchstaller, (unknown), Dieter Dorsch, Daniel Kühn, Martin Lehmann, Birgitta Leuthner, Djordje Müsil, (unknown), (unknown), Felix Rohdich, Richard Schneider, Christina Esdar	28
13	Novel reversible methionine aminopeptidase-2 (MetAP-2) inhibitors based on purine and related bicyclic templates 2016 ·Bioorganic & Medicinal Chemistry Letters ·Timo Heinrich, Hans‐Peter Buchstaller, (unknown), Felix Rohdich, Jörg Bomke, Manja Friese‐Hamim, Mireille Krier, Thorsten Knöchel, Djordje Müsil, Birgitta Leuthner, Frank T. Zenke	18
14	Structure-based optimization of non-peptidic Cathepsin D inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ulrich Grädler, Paul Czodrowski, (unknown), Markus Klein, (unknown), S. Lindemann, K. Maskos, Birgitta Leuthner	21
15	A H2O2-producing glyoxal oxidase is required for filamentous growth and pathogenicity in Ustilago maydis 2004 ·Molecular Genetics and Genomics ·Birgitta Leuthner, (unknown), (unknown), (unknown), Olaf Müller, Philip Müller, Regine Kahmann, Michael Bölker, Peter Schreier	82
16	Operon structure and expression of the genes for benzylsuccinate synthase in Thauera aromatica strain K172 2001 ·Archives of Microbiology ·(unknown), Birgitta Leuthner, Johann Heider	42
17	A two-component system involved in regulation of anaerobic toluene metabolism in Thauera aromatica 1998 ·FEMS Microbiology Letters ·Birgitta Leuthner, Johann Heider	41
18	A two-component system involved in regulation of anaerobic toluene metabolism in Thauera aromatica 1998 ·FEMS Microbiology Letters ·Birgitta Leuthner	1
19	Biochemical and genetic characterization of benzylsuccinate synthase from Thauera aromatica: a new glycyl radical enzyme catalysing the first step in anaerobic toluene metabolism 1998 ·Molecular Microbiology ·Birgitta Leuthner, Christina Leutwein, Henk Schulz, Patric Hörth, Wolfgang Haehnel, Emile Schiltz, Hermann Schägger, Johann Heider	234
20	Differential induction of enzymes involved in anaerobic metabolism of aromatic compounds in the denitrifying bacterium Thauera aromatica 1998 ·Archives of Microbiology ·Johann Heider, Matthias Boll, (unknown), Sabine Breinig, Christa Ebenau‐Jehle, (unknown), Nasser Gad’on, (unknown), Birgitta Leuthner, Magdy El‐Said Mohamed, Sabine Schneider, Gerhard Burchhardt, Georg Fuchs	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact